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Abstract
Extracellular matrix associated Sparc-like 1 (SC1/SPARCL1) can influence the function of
astroglial cells in the developing and mature central nervous system (CNS). To examine SC1’s
significance in the CNS, we generated a BAC transgenic mouse model in which Sc1 is expressed
in radial glia and their astrocyte derivatives using the astroglial-specific Blbp (Brain-lipid binding
protein; [Feng et al., (1994) Neuron 12:895–908]) regulatory elements. Characterization of these
Blbf-Sc1 transgenic mice show elevated Sc1 transcript and protein in an astroglial selective
pattern throughout the CNS. This model provides a novel in vivo system for evaluating the role of
SC1 in brain development and function, in general, and for understanding SC1’s significance in
the fate and function of astroglial cells, in particular.
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INTRODUCTION
SC1 is a member of the SPARC (Secreted Protein Acidic and Rich in Cysteine) family of
extracellular matrix-associated proteins, which, in addition to SC1 and SPARC, includes
testicans 1–3, tsc36, QR1, and SMOCs. This family of proteins is defined by the presence of
a highly acidic domain I, a follistatin-like domain, and an extracellular calcium (EC) binding
domain [reviewed in (Brekken and Sage, 2000; Framson and Sage, 2004; Yan and Sage,
1999)]. The follistatin-like domain, which shares homology to a repeated domain in
follistatin, consists of a Kazal-type serine protease inhibitor region and an EGF domain. The
EC binding domain contains a canonical pair of Ca2+ binding EF-hand motifs (Yan and
Sage, 1999). The N-terminal domains of each family member exhibit the greatest
divergence, and testican and tsc36/FRP both contain unique C-termini domains not present
in the other members of SPARC family (Yan and Sage, 1999).
SPARC family members appear to function primarily as anti-adhesion signals. For example,
SC1/hevin has been shown to inhibit attachment and spreading of endothelial cells on
fibronectin in vitro (Girard and Springer, 1996). Similarly, SPARC has been shown to
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inhibit the formation of focal adhesion contacts by a tyrosine phosphorylation-dependant
pathway, resulting in reduced adhesivity of endothelial cells in vitro (Motamed and Sage,
1998; Murphy-Ullrich et al., 1995). SPARC can also regulate cell adhesion by modulating
the production and activity of matrix metalloproteinases involved in ECM remodeling
(Gilles et al., 1998), by binding and sequestering Ca2+ through its EC domain, or through its
association with ECM components such as vitronectin and collagen types I, III, IV, and V
(Maurer et al., 1995; Sasaki et al., 1998). Additionally, SPARCs can function to inhibit cell
cycle progression and modulate growth factor activity (Brekken and Sage, 2000, 2001;
Brekken et al., 2004).
Although the SPARC family of proteins are expressed in the developing and adult CNS,
their functional significance in the brain remains, for the most part, unclear (Brekken et al.,
2004). Recent studies have identified that the selective expression of SC1 in radial glial
strands spanning the cortical plate (CP) enables it to influence the terminal phase of
neuronal migration in the developing cerebral cortex (Gongidi et al., 2004). In the adult
cerebral cortex, SC1 is enriched in postsynaptic terminals and in perisynaptic glial processes
surrounding the synapse (Lively et al., 2007). Following injury, reactive astrocytes rapidly
upregulate SC1 (McKinnon and Margolskee, 1996; Mendis et al., 1996a; Lively et al.,
2007). Although these studies suggest potentially important roles for SC1 in the
development, maturation, and function of the brain, further elucidation of SC1’s significance
has been hampered by the lack of methods to selectively modulate SC1 expression and
function in vivo in cells that mainly express it, i.e., astroglia.
Here, we describe the generation and characterization of a bacterial artificial chromosome
(BAC) transgenic mouse line that expresses Sc1 under the transcriptional control of the
Brain lipid-binding protein (Blbp or fatty acid binding protein 7, Fabp7) regulatory elements
(Feng et al., 1994; Xu et al., 1996). This promoter region has been well characterized and
used successfully to drive gene expression selectively in radial glia and their astrocytic
progeny from embryonic day 13 onwards in the developing CNS (Anthony et al., 2004,
2005; Feng and Heintz, 1995). Utilization of the BAC transgenic approach allows for
selective expression of SC1 in BLBP+ astroglial cells under more stable conditions than
traditional transgenic approaches (Heintz, 2001). Widespread expression of SC1 was
achieved in astroglial cells of the cerebral cortex, hippocampus, midbrain, and cerebellum in
these mice. Generation of these mice provides a novel tool for the analysis of the role of
SC1 in distinct compartments of the developing and adult mammalian brain.
METHODS
Construction of SC1-IRES-EYFPm BAC Transgene Construct
SCI-IRES-EYFPm-pA was cloned into pCMV-Zeo (Invitrogen, V50120). CMV-Zeo was
then replaced with floxed Neo cassette from p452 (a gift from Dr. N. Copeland of NCI) to
introduce Neo as a selection marker for recombineering and to provide additional unique
sites of restriction endonuclease to ligate with homologous arms for targeting. The SC1-
IRES- EYFPm-pA was then inserted into Blbp exon 1 within C57 mouse BAC
(RP23-81N21). With the deletion of 160 bp of exon 1 and part of intron 1, this transgene
starts transcription after 39nt from the Blbp transcription initiation site (Fig. 1A).
Generation of BAC Transgenic Mice
Purified BAC was used for pronuclear microinjection of fertilized eggs from the CBA X
C57Bl6 mouse strain at the UNC Animal Model core facility. Fertilized ovum was
subsequently implanted into pseudo-pregnant females and offspring were analyzed for the
insertion of the BAC construct. Founder lines were identified by Southern blot analysis of
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tail DNA (Fig. 1C). An [α-32P] dCTP labeled DNA probe was generated from an 857 bp
NheI-BsrGI fragment of the pEYFPm plasmid and used to probe the DNA blot. Independent
breeding lines were established from four of the founders (named Blbp-Sc11–4) and
subsequent offspring were analyzed by PCR, using the following primers, 5′ CCA AGA
CCA GGT ACC ATG 3′ and 5′ GCC AGG GTT TTC CCA GT 3′, complimentary to exon
2 of the Blbp BAC (RP23-81N21) and EYFP, respectively. Blbp-Sc11–4 lines were
maintained on a C57Bl6 background and all animals were housed under identical conditions.
All procedures were carried out in accordance with NIH guidelines and The University of
North Carolina’s Animal Care and Use Committee Guidelines.
In Situ Hybridization
Sc1 probe spans sequence #902–1832 of the mouse Sc1 cDNA sequence. The Sc1 in situ
construct was generated by RT-PCR from mouse brain cDNAs using Sc1 specific primers
(5′ GGC TGA AGA AAG CCA GAC AC 3′ and 5′ CTG CAG TTG GTG TCC CTT TT
3′) and the 930 bp amplified product was cloned into pBluescript SK(+). After linearization
with EcoRV, antisense transcripts were produced using T7 RNA polymerase. In situ
hybridization on brain sections from Blbp-Sc1 transgenic and wildtype control mice was
performed as previously described (Anton et al., 2004) at the UNC Neuroscience Center’s in
situ hybridization core facility. All images were captured under identical conditions using an
Axio-Cam camera attached to a Zeiss Axioplan 2 microscope. The relative levels and spatial
distribution of transgene expression was determined by reviewing multiple sections from
different Blbp-Sc1 transgenic lines and by comparison to sense control labeled slides.
Quantitative Real-Time-PCR
To assess the relative expression levels of Sc1 in the Blbp-Sc1 transgenic lines, RNA was
extracted from Blbp-Sc1 transgenic or wildtype cortex and cerebellum using Trizol
(Invitrogen). High fidelity cDNA was generated from each RNA sample (SuperScript II,
Invitrogen). QRT-PCR reaction samples were prepared as a mixture containing Sybergreen
POWER Universal Master Mix™ (Synthegen), forward and reverse primers for Sc1 or
Gapdh, and equal amounts of cDNAs. The following primers were used: Gapdh, 5′-
TGTGTCCGTCGTGGATCTGA-3′ and 5′-CCTGCTTCACCACCTTCTTGA-3′; Sc1, 5′-
GGCTGAAGAAAGCCAGACAC-3′ and 5′-GTGTCCTTCTGGTTGCCAAT-3′.
Reactions were performed using an Applied Biosystems Prism 9700 PCR machine. Relative
expression of Sc1 levels (Sc1/Gapdh) in wildtype and Blbp-Sc1 samples was determined as
described by Pfaffl 2001.
Immunohistochemistry and Immunoblotting
Wildtype and Blbp-Sc1 brains were harvested and processed for immunohistochemistry or
immunoblotting as described earlier (Gongidi et al., 2004; Schmid et al., 2003). Briefly,
brain tissue was either fixed in 4% paraformaldehyde for immunohistochemistry or flash
frozen for Western blot analysis. Fixed brains were sagittally sectioned (30 µm thick) and
processed for immunolabeling with a rat anti-SC1 antibody [11–59, generous gift of Dr. E.
Helene Sage, The Hope Heart Institute]. Immunoreactivity was detected with Cy2
conjugated, anti-rat secondary antibodies (Jackson Immunoresearch). For Western blot
analysis, harvested brains were homogenized in lysis buffer [20 mM Tris, pH 7.4, 150 mM
NaCl, 10% Glycerol, 1% NP40, 0.25% Deoxycholate, 0.1% SDS, and protease inhibitors
(Sigma)]. Equal amounts of proteins were then separated on 4–20% gradient SDS-PAGE
gels and immunoblotted with anti-SC1 antibodies as described in Gongidi et al., 2004.
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Generation of SC1-IRES-EYFPm BAC Transgenic Mouse Model
To test SC1 functions in the developing and mature brain, we have generated a BAC
transgenic mouse model where SC1/SPARCL1 is expressed specifically in radial glial cells
and their astrocyte derivatives using the astroglial specific Blbp (Brain lipid-binding protein
or fatty acid binding protein 7, Fabp7) regulatory elements. Disrupted normal Sc1
expression in the developing and mature astroglial cells in these Blbp-Sc1 transgenic mice
provides a framework to evaluate the role of astroglial SC1 in the brain. Previous studies
have shown that the Blbp regulatory elements can drive gene expression in an astroglial-
specific manner starting around embryonic day 13 (Anthony et al., 2004, 2005; Feng and
Heintz, 1995). A SCI-IRES-EYFPm-pA construct containing Sc1, separated from the
enhanced, membrane targeted yellow fluorescent protein (EYFPm) by an internal ribosomal
entry signal (IRES), was generated and cloned into pCMV-Zeo (Invitrogen, V50120).
CMV-Zeo was then replaced with floxed Neo cassette from p452 (a gift from Dr. N.
Copeland of NCI) to introduce Neo as a selection marker for recombineering and to provide
additional unique sites of restriction endonuclease to ligate with homologous arms for
targeting. The Sc1-IRES- EYFPm-pA was then inserted into Blbp exon 1 within C57 mouse
BAC (RP23-81N21). With the deletion of 160 bp of exon 1 and part of intron 1, the
transgene starts after 39nt from the Blbp transcription initiation site (Fig. 1A). Prior to
generation of BAC-transgenic mice, Blbp-Sc1 plasmids were electroporated into the
ventricles of embryonic day 15 mice to ensure that transgene expression in the developing
cerebral cortex was restricted to radial glial cells (Schmid et al., 2006).
The purified BAC construct was used for pronuclear microinjection of fertilized eggs from
C57B16 strain mice at UNC Animal Models core facility. Six founder lines were identified
by Southern blot analysis of tail DNA using a probe for the Blbp-Sc1 transgene (Fig. 1B).
Independent breeding lines were established from four of these lines (named Blbp-Sc11–4).
Expression of this transgene does not appear to affect the overall viability of transgene
positive progeny.
Characterization of Blbp-Sc1 Transgene Expression
We initially performed in situ hybridization to examine the Sc1 expression pattern in the
CNS of Blbp-Sc1 transgenic lines and control wildtype mice. Compared to wildtype cerebral
cortex, elevated Sc1 expression is evident throughout the cortex (Fig. 2B and C). Although
there was a marked elevation in expression in all regions of the cerebral cortex, the most
striking rise in Sc1 expression was seen in the region of occipital and parietal cortex. In the
hippocampus, widespread increase in astroglial Sc1 expression was noticed, especially in the
regions of the subiculum, CA3, and dentate gyrus (Fig. 2D and E). In the striatum, stellate
shaped, multipolar astroglial cells prominently expressed Sc1 (Fig. 2F and G). Furthermore,
significant upregulation of Sc1 in Bergmann glia of the cerebellum was also evident in these
transgenic lines (Fig. 2H–K). Labeling with Sc1 sense control probes showed no detectable
signal (data not shown).
To further demonstrate that introduction of the Blbp-Sc1 transgene resulted in an
upregulation of Sc1 expression within the CNS of these transgenic lines, we performed
quantitative RT-PCR (QRT-PCR) analysis of Sc1 expression in the cortex and cerebellum of
Blbp-Sc1 mice using Sc1 specific primers. These findings reveal a significant increase in the
level of Sc1 transcript in the cerebral cortex and cerebellum of Blbp-Sc1 transgenic mice
when compared to wildtype controls (Fig. 2L).
To determine whether the upregulation of Sc1 mRNA in the Blbp-Sc1 transgenic mice
corresponds to an increase in SC1 protein expression, we performed immunoblot analysis of
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whole cell extracts from Blbp-Sc1 cerebral cortex. Increase levels of the 116 kDa SC1
protein was noticed in Blbp-Sc1 cortices (Fig. 3E). Moreover, immunolabeling of sections
of cerebral cortex and cerebellum with anti-SC1 antibodies indicates increased levels of SC1
in both the cerebral cortex as well as the cerebellum of Blbp-Sc1 transgenic mice (Fig. 3).
SC1 expression is apparent in astroglial cells throughout the cortex (Fig. 3A and B). In
cerebellum, Bergmann glial cells and their processes selectively express enhanced levels of
SC1 (Fig. 3C and D). Taken together, these in situ hybridization observations, QRT-PCR
analysis, immunoblotting, and immunohistochemical evaluation of Blbp-Sc1 transgenic
mice demonstrate that SC1 is over-expressed in an astroglial-specific manner in these mice
and thus, they provide an in vivo model to examine the significance of astroglial restricted
SC1 expression and function in the CNS.
DISCUSSION
Generation and characterization of a BAC transgenic mouse model in which astroglial
selective over-expression of SC1 is achieved will facilitate the analysis of SC1 functions,
particularly those mediated through astroglia, in the development and maturation of distinct
brain structures. Considering the known functional redundancy of SPARC family of proteins
in the brain and the entailing difficulties in using traditional knock-out approach to delineate
functional significance of SPARC family members (Gilmour et al., 1998; McKinnon et al.,
2000; Roll et al., 2006), this approach provides a useful model to analyze SC1 function in a
cell type specific manner in the brain.
SC1’s expression in the developing, mature, and injured brain suggests that it may influence
multiple cellular processes during distinct stages of brain development and function. In the
embryonic brain, SC1 is prominently expressed in radial glia where it functions to terminate
radial glial guided neuronal migration by reducing the adhesivity of neurons to the radial
glial scaffold (Gongidi et al., 2004). Furthermore, SC1 is also expressed in the proliferative
ventricular zone (VZ) of the embryonic cortex where it may influence the dynamics of radial
glial cell proliferation and survival (Girard and Springer, 1995, 1996; Gongidi et al., 2004).
Additionally, the presence of anti-adhesive signals such as SC1 in the VZ may play a role in
turning VZ directed subpopulation of neurons back on a trajectory towards the CP
(Nadarajah et al., 2002; Yokota et al., 2007). The selective SC1 expression in the VZ and
CP, and the differential function of SC1 in distinct cerebral wall domains could, in turn,
provide a mechanism for the coordination of neural precursor proliferation and neuronal
placement in the developing neocortex. SC1 is also expressed in Bergmann glia of the
developing cerebellum, where selective transport of SC1 may influence glial guided
migration or modulation of synaptic activity (Brekken et al., 2004; Mothe and Brown,
2000). In the mature brain, SC1 expression persists in radial glial derivatives, that is,
astrocytes. SC1 expression in astrocytes adjacent to synapses is hypothesized to modulate
synaptic function (Lively et al., 2007). These varied functions of SC1 that are mediated
through radial glia or astrocytes could be further evaluated using Blbp-Sc1 transgenic lines
where normal expression of SC1 is selectively disrupted in these cells.
Following brain injury, SC1 is rapidly upregulated in reactive astrocytes around the site of
injury (Lively and Brown, 2007; McKinnon and Margolskee, 1996; Mendis et al., 1996a,b).
This upregulation in astrocytes may enhance the repair process following injury and the
Blbp-Sc1 transgenic mouse model could help to evaluate this possibility. Although the exact
levels of SC1 upregulation necessary to induce repair mechanism follow focal trauma has
not been established, the Blbp-Sc1 transgenic mouse model induces an over 30-fold
induction of Sc1 mRNA expression in the adult cerebral cortex and over 5-fold induction in
the cerebellum. Furthermore, SC1 may also be involved in the pathogenesis of multiple
neural traumas. For example, proteomic analysis of cerebrospinal fluid from multiple
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sclerosis patients showed an upregulation of SC1 expression (Scalabrini et al., 2007). SC1
may also function as a tumor suppressor and is aberrantly expressed in brain tumors
(Framson and Sage, 2004; Sullivan and Sage, 2004). SC1’s ability to remodel extracellular
matrix, regulate cell cycle progression, and act as substrate for apoptosis regulators, such as
caspase-3, may be highly relevant to its function in these aberrantly proliferating and
invasive brain tumor cells (Hambrock et al., 2003; Ju et al., 2007; Sullivan et al., 2006).
Blbp-Sc1 transgenic lines could be crossed with various mouse brain tumor models (Uziel et
al., 2005; Xiao et al., 2002; Zurawel et al., 2000) to evaluate if enhanced astroglial SC1
expression could modulate the formation and progression of gliomas.
In summary, SC1 expression in the astroglial cells of the developing, mature, and injured
brain is highly suggestive of dynamic functions of this protein in the CNS. The generation of
a Blbp-Sc1 transgenic mouse model described here provides a useful system for determining
in vivo how astroglial expression of SC1 contributes to the construction and function of
distinct brain regions.
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Generation of Blbp promoter- SC1-IRES-EYPm mice. (A) BLBP BAC clone
(RP23-81N21), indicating the location of Blbp and nearby genes, Pkib and Smapdl3a. (B)
Insertion of transgene (SCI-IRES-EYFPm-pA) into Blbp BAC clone. Integration of the
transgene by homologous recombination, followed by selection of the targeted BAC clone,
and removal of the Neo- cassette. BLBP-SCI-IRES-EYFPm-pA transgene thus generated
was used to drive astroglial specific expression of Sc1 in the developing and mature brain.
(C) Six founder lines were identified by Southern blot analysis of tail DNA and independent
breeding lines were established from four (named Blbp-Sc11–4). (D) A single PCR product
Weimer et al. Page 9













of ~950-bp size was detected with primers complementary to Blbp-BAC and EYFP from
Blbp-Sc11–4 DNA. The transgene plasmid was used as a positive control (+ lane) and DNA
isolated from wildtype mice (− lane) was used as a negative control. [Color figure can be
viewed in the online issue, which is available at www.interscience.wiley.com.]
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Patterns of Sc1 expression in Blbp-Sc1 transgenic mice. In situ hybridization analysis
demonstrated elevated expression of Sc1 transcript in distinct regions of the CNS of Blbp-
Sc1 transgenic mice. Sc1 expression in Blbp-Sc1 transgenic mice (C, E, G, I, K) was
compared with age-matched controls (B, D, F, H, J). Regions examined are indicated on a
schematic of the sagittal view of adult brain (A) Sc1 expression is upregulated in cerebral
cortex (B, C); hippocampus (D, E); striatum (F, G); cerebellum (H–K). Arrowheads (G)
indicate Sc1 overexpressing multipolar astrocytes in the striatum. Higher magnification
images of the cerebellum indicates prominent Sc1 overexpression in Bergmann glia with
elongated processes in Blbp-SC1 mice (arrowheads, K). Quantitative RT-PCR analysis with
Sc1 specific primers reveals a significant increase in the level of Sc1 transcript in both the
cerebral cortex and cerebellum of Blbp-Sc1 transgenic mice compared to wildtype controls
(L). Data shown are mean ± SD. Asterisks indicates significance compared with controls at
P < 0.001 (Student’s t test). S, subiculum; DG, dentate gyrus; ML, molecular layer; PL,
Purkinje layer; GL, granule layer. [Color figure can be viewed in the online issue, which is
available at www.interscience.wiley.com.]
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Elevated expression of SC1 in the cerebral cortex and cerebellum of Blbp-Sc1 transgenic
mice sections of adult cortex and cerebellum were immunolabeled with anti-SC1 antibodies.
Increased levels of SC1 are seen in astroglial cells of Blbp-Sc1 transgenic mice within both
the cortex (B) and the cerebellum (D), as compared to basal levels of SC1 expression in
wildtype mice (A [cortex], C [cerebellum]). Arrowheads (D) indicate Bergmann glia of the
cerebellum. Immunoblot analysis of Blbp-Sc1 brains demonstrates an increase in the levels
of the 116 kDa SC1 protein (E). Arrowhead (E) indicates the unprocessed precursor of SC1.
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[Color figure can be viewed in the online issue, which is available at
www.interscience.wiley.com.]
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